Physician profile
James D Kondrup
NPI 1376648337
$309,586.09
in general payments reported to CMS, 2019-2025
29 companies · $12K in 2025
The $12K reported for 2025 was more than what 96% of Gynecology providers received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $122K · 2020: $55K · 2021: $50K · 2022: $39K · 2023: $8,755 · 2024: $22K · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $33K · Honoraria: $7,963 · Food and Beverage: $995 · Travel and Lodging: $674.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $33,350.00 |
| Honoraria | $7,962.50 |
| Food and Beverage | $994.87 |
| Travel and Lodging | $674.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $222,414.35 | 2019-2022 | |
| Ethicon INC. | $29,600.00 | 2020-2025 | |
| Medical Device Business Services, INC. | $25,219.79 | 2019-2021 | |
| Myriad Women'S Health, INC. | $8,369.99 | 2023 | Myrisk, Genesight |
| Intuitive Surgical, INC. | $6,585.70 | 2019-2021 | |
| Distalmotion US | $6,521.85 | 2024 | Dexter L6 Robot |
| Ethicon US, LLC | $4,306.00 | 2019-2022 | |
| Asensus Surgical, INC. | $3,933.28 | 2019 | |
| Ethicon Endo-Surgery INC. | $1,250.00 | 2022 | |
| Organon LLC | $592.31 | 2021-2025 | Follistim Aq, Pregnyl, Ganirelix Acetate |
| Emd Serono, INC. | $262.68 | 2021-2023 | |
| Pacira Pharmaceuticals Incorporated | $81.29 | 2019 | |
| Sumitomo Pharma America, INC. | $50.70 | 2023 | Myfembree |
| Myovant Sciences INC. | $45.07 | 2021-2022 | |
| Coopersurgical, INC. | $43.90 | 2022-2023 | Stripper |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $42.78 | 2021 | |
| Amag Pharmaceuticals, INC. | $33.52 | 2019 | |
| Ferring Pharmaceuticals INC. | $30.11 | 2023 | Menopur |
| Astellas Pharma US INC | $24.13 | 2019 | |
| Therapeuticsmd, INC. | $22.01 | 2019 | |
| Hologic Sales and Service, LLC | $21.65 | 2019 | |
| Johnson & Johnson Health Care Systems INC. | $19.71 | 2019 | |
| Covidien Lp | $19.09 | 2019 | |
| Minerva Surgical, INC | $19.06 | 2019 | |
| Amgen INC. | $18.70 | 2019 | |
| Duchesnay USA Incorporated | $18.00 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.60 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $12.55 | 2022 | |
| Allergan, INC. | $11.27 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Kondrup listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.